These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21998659)

  • 1. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.
    Zinn PO; Mahajan B; Sathyan P; Singh SK; Majumder S; Jolesz FA; Colen RR
    PLoS One; 2011; 6(10):e25451. PubMed ID: 21998659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
    Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
    J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
    Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
    Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
    Jamshidi N; Diehn M; Bredel M; Kuo MD
    Radiology; 2014 Jan; 270(1):1-2. PubMed ID: 24056404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma.
    Kong DS; Kim J; Lee IH; Kim ST; Seol HJ; Lee JI; Park WY; Ryu G; Wang Z; Ma'ayan A; Nam DH
    Oncotarget; 2016 Mar; 7(10):11526-38. PubMed ID: 26863628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death.
    Colen RR; Wang J; Singh SK; Gutman DA; Zinn PO
    Radiology; 2015 Apr; 275(1):215-27. PubMed ID: 25490189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
    Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
    Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing molecular profiles of glioblastoma with GBM-BioDP.
    Celiku O; Johnson S; Zhao S; Camphausen K; Shankavaram U
    PLoS One; 2014; 9(7):e101239. PubMed ID: 25010047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
    Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
    Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
    Huang YT; Hsu T; Kelsey KT; Lin CL
    Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance.
    Qian X; Tan H; Liu X; Zhao W; Chan MD; Kim P; Zhou X
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
    BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.